Salah Adlat Selected Research

atractylenolide II

7/2021	Atractylenolide II induces cell cycle arrest and apoptosis in breast cancer cells through ER pathway.
12/2018	Atractylenolide II Induces Apoptosis of Prostate Cancer Cells through Regulation of AR and JAK2/STAT3 Signaling Pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salah Adlat Research Topics

Disease

2	Neoplasms (Cancer) 07/2021 - 01/2021
2	Inflammation (Inflammations) 02/2021 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 12/2018
1	Brain Ischemia (Cerebral Ischemia) 01/2022
1	Reperfusion Injury 01/2022
1	Breast Neoplasms (Breast Cancer) 07/2021
1	Autoimmune Diseases (Autoimmune Disease) 02/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Leiomyosarcoma 01/2021
1	Rheumatoid Arthritis 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Body Weight (Weight, Body) 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Obesity 01/2019

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 07/2021 - 12/2018
2	atractylenolide IIIBA 07/2021 - 12/2018
2	CytokinesIBA 02/2021 - 01/2020
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2022
1	NF-kappa B (NF-kB)IBA 07/2021
1	LigandsIBA 02/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2020
1	diphenyleneiodoniumIBA 01/2020
1	hydroxide ionIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	TEMPOIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2021
1	Radiotherapy 01/2021